Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ketoconazole and Quinidine

supplement:

Quinidine

Research Papers that Mention the Interaction

Ketoconazole , which is a potent inhibitor of CYP3A4/5, had a strong inhibitory effect on their formation, and the M4 formation from R(+)-cibenzoline was inhibited by quinidine by 45%.
Drug metabolism and disposition: the biological fate of chemicals  •  2000  |  View Paper
In pooled human liver microsomes, formation of both metabolites was partially inhibited by both quinidine and ketoconazole , suggesting that CYP2D6 and CYP3A enzymes are involved in the metabolism of CJ-12,458.
Drug metabolism and disposition: the biological fate of chemicals  •  2001  |  View Paper
In human liver microsomes, the mean K(m) (+/-S.E. ) was 14.4 +/- 2.0 microM. A screen of the chemical inhibitors omeprazole (10 microM), quinidine (10 microM), sulfaphenazole (10 microM), and ketoconazole (2.5 microM) only revealed detectable inhibition with ketoconazole.
Drug metabolism and disposition: the biological fate of chemicals  •  2000  |  View Paper
Quinidine almost completely inhibited the CYP2D6-mediated de-esterification at the concentration of 1 x 10(-6) M. Ketoconazole and troleandomycin inhibited the CYP3A4-mediated reaction in a dose-related manner.
Drug metabolism and disposition: the biological fate of chemicals  •  1999  |  View Paper
Ketoconazole had the most pronounced inhibitory effect on the biotransformation of both substrates, while for quinidine and furafylline there was only a weak or no influence.
European Journal of Clinical Pharmacology  •  1999  |  View Paper
Formation of all three products was reduced to approximately 20% of control values by 1 μM ketoconazole; quinidine at 1 μM produced a small reduction in formation (91–94% of control) of two of the metabolites.
Psychopharmacology  •  1998  |  View Paper
Ketoconazole , an inhibitor of CYP3A4, inhibited competitively CPHP formation (Ki=0.1 microM), whereas sulphaphenazole (CYP2C9), furafylline (CYP1A2) and quinidine (CYP2D6) gave only little inhibition (IC50 > 100 microM).
British journal of clinical pharmacology  •  1997  |  View Paper
Dual inhibitors of both P-gp and Cyp3a (verapamil and ketoconazole ) increased the concentration of Qi in the jejunum and ileum, but less 3-hydroxy-quinidine was produced due to inhibition of Cyp3a.
Drug Metabolism and Disposition  •  2016  |  View Paper
The analysis of the obtained pharmacokinetic parameters showed that, KTZ significantly reduced total body clearance of QUN by 35%, while CIM did not.
The Journal of veterinary medical science  •  2009  |  View Paper
Co-administration of KTZ increased C(max) of QN to about 1.5-fold.
Journal of veterinary pharmacology and therapeutics  •  2004  |  View Paper